Supplementary Protection Certificate (SPC) Summary | |||
SPC No. | 1999/002 | ||
---|---|---|---|
Date of filing | 26/02/1999 | ||
Notification of Application Published | |||
Status | Rejected | ||
Notification of Grant Published | |||
Date of Expiry of SPC | |||
Applicant |
NOVARTIS AG Schwarzwaldallee 215 4058 Basel SWITZERLAND |
||
Patent Number | 71155 | ||
Title of Invention | Acyl compounds | ||
Date of Expiry of Patent | 17/02/2011 | ||
Product Type | Medicinal Product | ||
Product Identity | Valsartan or a pharmaceutically acceptable salt or ester thereof in combination with hydrochlorothiazide | Market Authorisation | Ireland | France |
Authorisation No | PA 13/91/1 | 344 300-5 | |
Authorisation Date | 10/12/1998 | 25/09/1997 | |
Identity of Product Authorised | COTAREG | ||
Market Authorisation | France | ||
Authorisation No | 344 301-1 | ||
Authorisation Date | 25/09/1997 | ||
Identity of Product Authorised | COTAREG | ||
Market Authorisation | France | ||
Authorisation No | 344 302-1 | ||
Authorisation Date | 25/09/1997 | ||
Identity of Product Authorised | COTAREG | ||
Market Authorisation | France | ||
Authorisation No | 344 303-4 | ||
Authorisation Date | 25/09/1997 | ||
Identity of Product Authorised | COTAREG | ||
Address for Service |
FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 IRELAND |
||
Renewal Fees | |||
10/03/2006 | Request for grant of Supplementary Protection Certificate No. 1999/002 rejected in respect of Article 10(2) of Council Regulation (EEC) No. 1768/92. [Journal No. 2043, 05/04/2006] | ||
20/12/2007 | Appeal by Novartis against the rejection of Supplementary Protection Certificate application dismissed by the High Court. | ||
24/03/2021 | Written grounds of decision issued on 10 March 2005. |